MsMocha

Remain ACTIVELY patient whilst working towards your DREAMS!!!!......

[MsMocha @Lady_KTGR]

#nycprotest #BlackLivesMatter #lethimlive #Brooklynprotest.
This made me smile.. when the crowd stopped offered a round of applause and cheered him on....#

[MsMocha @Lady_KTGR]

@samuelwcook Big contract or Amazon buy out??

[MsMocha @Lady_KTGR]

@BillyM2k 👍🏿

[Harry Sisson @harryjsisson]

So Trump basically gave Iran everything they wanted and we got the Strait of Hormuz opening… which was already open before the war started. ART OF THE DEAL EVERYONE!

[MsMocha @Lady_KTGR]

@vulturetrades Ready

[Investor News @newsfilterio]

Ardelyx Announces US Launch of IBSRELA®, a New First-in-Class Treatment for IBS-C in Adults $ARDX https://t.co/JUBZJQmKu7

[Ardelyx @ardelyx]

Ardelyx announces a new treatment option for adults with IBS-C.

https://t.co/eUOz6P5fDZ

[MsMocha @Lady_KTGR]

$ONTX

[OncLive.com @OncLive]

Rigosertib/Nivolumab Combo Shows Early Potential in KRAS-Mutated NSCLC #lcsm https://t.co/qWfd3YAL05

[OnconovaTherapeutics @Onconova_ONTX]

Onconova Therapeutics Provides an Update on the Phase 1/2a Trial of Rigosertib-Nivolumab Combination in KRAS+ Non-Small Cell Lung Cancer https://t.co/kMK9iTpSjH

[Manni @TipAktien]

#aktientip Request to the EMA (Europe) about Rigosertib.
With the conditional marketing authorization (CMA), a drug can be approved in Europe as soon as the first study data with a positive risk-benefit ratio are available.
$ONTX

[MsMocha @Lady_KTGR]

@MrZackMorris $ONTX

[MsMocha @Lady_KTGR]

$ONTX
$TSLA $OCGN $CTRM $ZOM $SNDL

https://t.co/MUWfDCVrNf

[MsMocha @Lady_KTGR]

$ONTX $AMC $SNDL $HCMC
$GME $BABA

[stock setter @MarcJacksonLA]

$ONTX Onconova Therapeutics Announces the Peer-Reviewed Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Rigosertib Combined with Immune Checkpoint Blockade https://t.co/ezijXL9OQN

[OnconovaTherapeutics @Onconova_ONTX]

Onconova Therapeutics Announces the Peer-Reviewed Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Rigosertib Combined with Immune Checkpoint Blockade https://t.co/NO8I3BzFx7

[MsMocha @Lady_KTGR]

$ontx

[OnconovaTherapeutics @Onconova_ONTX]

Onconova Therapeutics Announces the Peer-Reviewed Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Rigosertib Combined with Immune Checkpoint Blockade https://t.co/NO8I3BzFx7

[Chef Boyardee @ChefBoy28416831]

$ONTX can we please get a catalyst to get this thing moving to these $20+ ranges?! 🤑🚀🚀🌝

[MsMocha @Lady_KTGR]

$ontx
$Amc $sndl $gme $hcmc

[OnconovaTherapeutics @Onconova_ONTX]

Onconova Therapeutics Announces Participation in A.G.P.’s Upcoming Virtual Summer Healthcare Symposium https://t.co/10cfwLqeUw

[Manni @TipAktien]

#aktientip The time has come for these stocks to rise:
$ONTX $TNXP $ACST
We have invested and are waiting.

[MsMocha @Lady_KTGR]

$ontx $amc $hcmc $doge

[Shubh Labh @SubhXLabh]

Onconova Therapeutics, Inc. ( $ONTX ) Upgraded to Buy: What Does It Mean for the Stock? https://t.co/N4rkZiASGS